Literature DB >> 29888650

Flexible and structured survival model for a simultaneous estimation of non-linear and non-proportional effects and complex interactions between continuous variables: Performance of this multidimensional penalized spline approach in net survival trend analysis.

Laurent Remontet1,2, Zoé Uhry1,2,3, Nadine Bossard1,2, Jean Iwaz1,2, Aurélien Belot4, Coraline Danieli5, Hadrien Charvat6, Laurent Roche1,2.   

Abstract

Cancer survival trend analyses are essential to describe accurately the way medical practices impact patients' survival according to the year of diagnosis. To this end, survival models should be able to account simultaneously for non-linear and non-proportional effects and for complex interactions between continuous variables. However, in the statistical literature, there is no consensus yet on how to build such models that should be flexible but still provide smooth estimates of survival. In this article, we tackle this challenge by smoothing the complex hypersurface (time since diagnosis, age at diagnosis, year of diagnosis, and mortality hazard) using a multidimensional penalized spline built from the tensor product of the marginal bases of time, age, and year. Considering this penalized survival model as a Poisson model, we assess the performance of this approach in estimating the net survival with a comprehensive simulation study that reflects simple and complex realistic survival trends. The bias was generally small and the root mean squared error was good and often similar to that of the true model that generated the data. This parametric approach offers many advantages and interesting prospects (such as forecasting) that make it an attractive and efficient tool for survival trend analyses.

Entities:  

Keywords:  Penalized spline; cancer net survival trends; generalized additive model; interaction; multidimensional smoothing; non-linear effect; non-proportional effect; survival model; tensor product; varying coefficient model

Year:  2018        PMID: 29888650     DOI: 10.1177/0962280218779408

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  4 in total

1.  Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal.

Authors:  Fabien Rollot; Justine Couturier; Romain Casey; Sandrine Wiertlewski; Marc Debouverie; Jean Pelletier; Jérôme De Sèze; Pierre Labauge; Aurélie Ruet; Eric Thouvenot; Jonathan Ciron; Eric Berger; Olivier Gout; Pierre Clavelou; Bruno Stankoff; Olivier Casez; Bertrand Bourre; Hélène Zephir; Thibault Moreau; Christine Lebrun-Frenay; Elisabeth Maillart; Gilles Edan; Jean-Philippe Neau; Alexis Montcuquet; Philippe Cabre; Jean-Philippe Camdessanché; Gilles Defer; Haifa Ben Nasr; Aude Maurousset; Karolina Hankiewicz; Corinne Pottier; Emmanuelle Leray; Sandra Vukusic; David-Axel Laplaud
Journal:  Neurotherapeutics       Date:  2022-02-25       Impact factor: 6.088

2.  Mortality among patients with low-grade follicular lymphoma: A binational retrospective analysis.

Authors:  Aino Rajamäki; Mika Hujo; Reijo Sund; Roosa E I Prusila; Milla E L Kuusisto; Hanne Kuitunen; Esa Jantunen; Santiago Mercadal; Marc Sorigue; Juan-Manuel Sancho; Kaisa Sunela; Outi Kuittinen
Journal:  Cancer       Date:  2022-04-13       Impact factor: 6.921

3.  Cancer incidence and mortality trends in France over 1990-2018 for solid tumors: the sex gap is narrowing.

Authors:  G Defossez; Z Uhry; P Delafosse; E Dantony; T d'Almeida; S Plouvier; N Bossard; A M Bouvier; F Molinié; A S Woronoff; M Colonna; P Grosclaude; L Remontet; A Monnereau
Journal:  BMC Cancer       Date:  2021-06-24       Impact factor: 4.430

4.  Prediction of cancer survival for cohorts of patients most recently diagnosed using multi-model inference.

Authors:  Camille Maringe; Aurélien Belot; Bernard Rachet
Journal:  Stat Methods Med Res       Date:  2020-12       Impact factor: 3.021

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.